2-218401669-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_021198.3(CTDSP1):c.173G>A(p.Ser58Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000373 in 1,606,928 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_021198.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CTDSP1 | NM_021198.3 | c.173G>A | p.Ser58Asn | missense_variant | 2/7 | ENST00000273062.7 | NP_067021.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CTDSP1 | ENST00000273062.7 | c.173G>A | p.Ser58Asn | missense_variant | 2/7 | 1 | NM_021198.3 | ENSP00000273062 | P3 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152186Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000287 AC: 7AN: 243892Hom.: 0 AF XY: 0.0000227 AC XY: 3AN XY: 132150
GnomAD4 exome AF: 0.00000344 AC: 5AN: 1454742Hom.: 0 Cov.: 32 AF XY: 0.00000276 AC XY: 2AN XY: 723486
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152186Hom.: 0 Cov.: 33 AF XY: 0.0000135 AC XY: 1AN XY: 74340
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 10, 2023 | The c.173G>A (p.S58N) alteration is located in exon 2 (coding exon 2) of the CTDSP1 gene. This alteration results from a G to A substitution at nucleotide position 173, causing the serine (S) at amino acid position 58 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at